Express Scripts' 2011 Drug Trend Report Reveals Strong Specialty Focus

Article

The specialty drug trend is projected to rise 17.1% in 2012, 19% in 2013, and 22% in 2014.

The specialty drug trend is projected to rise 17.1% in 2012, 19% in 2013, and 22% in 2014.

In 2011, 4 specialty classes—inflammatory conditions, multiple sclerosis (MS), cancer, and HIV—accounted for nearly 70% of spend for specialty drugs covered by pharmacy benefits, according to Express Scripts’ 2011 Drug Trend Report.

The report, which includes changes in prescription drug costs and utilization and provides insights on patient behaviors and market factors, is available for download now at http://express-scripts.com/research/research/dtr/. This year’s report focused on the waste that is produced by patient non-adherence and included an overview of the challenges, solutions, and trends that are expected with Medicare and Medicaid.

Many topics in the report have a strong specialty drug focus, especially in terms of the top 3 traditional therapy classes—inflammatory conditions, multiple sclerosis, and cancer. Specialty drugs saw greater cost increases, higher adherence, and a shift to higher cost therapies. Although the traditional drug trend is projected to be negative, the specialty drug trend is projected to rise 17.1% in 2012, 19% in 2013, and 22% in 2014. All of the top 10 classes in the analysis showed increases in total PMPY (per-member-per-year) medical spend, with trend for 4 classes exceeding 25%.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.